Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kramer-Novis is a specialty pharmaceutical company focused on the development and commercialization of high-quality therapeutic products for the pediatric, respiratory, and dermatological markets. The company maintains a diverse portfolio of prescription and over-the-counter (OTC) medications, including antihistamines, decongestants, and nutritional supplements. Kramer-Novis primarily serves the healthcare needs of patients in Puerto Rico and the United States through a targeted distribution network. Their business model emphasizes providing accessible and effective treatments for common respiratory conditions and pediatric health maintenance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kramer.